As of 2026-05-03, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,637.68 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 15.7x | 12.0x |
| Forward P/E multiples | 14.2x - 16.5x | 16.0x |
| Fair Price | (38.67) - (42.37) | (38.11) |
| Upside | -129.9% - -132.7% | -129.4% |
| Date | EV/EBITDA |